The Smart ICU Beds & Heads Market is expected to grow at a 5.5 % CAGR during the forecast period for 2023-2031. Smart beds are networked to give a variety of medical data, including personal data such as weight, body temperature, pulse, blood pressure, oxygen saturation, and other vital signs, medication, laboratory test results, allergies, and vaccination status. The increased need for state-of-the-art medical facilities, rising healthcar...
Report ID: 1324 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 185
The Proteome Profiling Services Market is expected to grow at an 11.5 % CAGR during the forecast period for 2023-2031. Proteome profiling refers to the high-throughput analysis of biological samples at a large scale for identifying, detecting, and functionalizing resident proteins, as proteins are complex biomolecules that involve various essential functions in living organisms. This process consists in studying polypeptide structure, function...
Report ID: 1346 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
The Infection Surveillance Solutions Market Size is valued at USD 544.93 Mn in 2022 and is predicted to reach USD 1581.37 Mn by the year 2031 at a 12.7 % CAGR during the forecast period for 2023-2031. The term "infection surveillance solutions" refers to systems continuously tracking and managing information on healthcare-associated infections (HAIs) for public health evaluation. The effective implementation of preventative interventions depen...
Report ID: 1988 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
The Animal Placental Protein Market Size is valued at USD 527.09 Mn in 2022 and is predicted to reach USD 837.97 Mn by the year 2031 at a 5.5% CAGR during the forecast period for 2023-2031. Animal placental proteins refer to proteins that are obtained from the placentas of various animal species. The placenta is an organ that undergoes development during pregnancy in the majority of animal species, including humans. Its initial function is to ...
Report ID: 2022 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
The Enzyme Immunoassay (EIA) Reagents and Kits Market Size is valued at 19.80 Billion in 2022 and is predicted to reach 31.60 Billion by the year 2031 at an 5.5 % CAGR during the forecast period for 2023-2031. Enzyme Immunoassay (EIA) test is one of laboratory technology that is used for measuring the concentration of analytes such as antigen and antibodies in solution. Enzyme Immunoassay (EIA) test includes various types of enzymes such as al...
Report ID: 1059 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 170
The Fragile X Syndrome Market Size is valued at 20.80 Million in 2022 and is predicted to reach 37.71 Million by the year 2031 at a 7.0 % CAGR during the forecast period for 2023-2031. Fragile X syndrome is a hereditary condition that causes a range of neurological problems, including cognitive impairment and learning disabilities. Males are more affected compare to females by this disorder. It causes delayed development of speech and lang...
Report ID: 1065 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
Global Heparin-Induced Thrombocytopenia (HIT) Treatment Market Size is valued at USD 9.38 billion in 2023 and is predicted to reach USD 13.55 billion by the year 2031 at a 4.81% CAGR during the forecast period for 2024 to 2031. Heparin-Induced Thrombocytopenia (HIT) Treatment Market Size, Share & Trends Analysis Report By Drug Types (Lepirudin, Danaparoid, Argatroban), By Test Types (Enzyme Immunoassay (EIA), Serotonin Release Assay (SRA), E...
Report ID: 2877 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 165
The Gene Therapies For Rare Diseases Market is expected to grow at an 20.0 % CAGR during the forecast period for 2023-2031. Gene Therapy is playing a major role in rare disease management. Gene therapy in rare diseases is a specialized and targeted treatment that acts via the insertion of corrected genes into cells of an individual. Around 80 percent of rare diseases are accounted with genetic etiology. Gene therapy is considered as proven wit...
Report ID: 1091 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 185
The Gene Therapy For Retinal Diseases Market is expected to grow at an 8.0 % CAGR during the forecast period for 2023-2031. Gene therapy states a method of announcing foreign DNA constructs into host cells in demand to treat various medical conditions, including retinal diseases. Gene therapy has an increasing research potential, mainly in the arena of retinal and ophthalmic diseases. The main features of the eye include convenience in terms o...
Report ID: 1157 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
The Pharmaceutical Fluid Handling Market Size is valued at USD 10.28 Bn in 2022 and is predicted to reach USD 15.31 Bn by the year 2031 at a 4.6% CAGR during the forecast period for 2023-2031. Pharmaceutical fluid handling is essential for delivering fluid medications such as cough syrups, intravenous medicines, and complicated active pharmaceutical components. Any firm that wants to flourish and be relied upon must invest in properly handling...
Report ID: 2048 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
Pharmaceuticals